Josh Enomoto

Josh Enomoto

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

AbbVie Stock: 3 Pros and 3 Cons to Consider Before Investing in ABBV

AbbVie has significant challenges, but they’re also not unique ones. Sizing up the outlook leads to a slightly bullish stance on ABBV stock.

3 Reasons Why Facebook’s Scandal Can’t Touch FB Stock

FB stock appears headed towards implosion after another scandal, but the company is simply too dominant to undo.

10 Marijuana Stocks to Ride High on the Farm Bill

Marijuana stocks have recently lagged the markets, but the newly signed farm bill provides a significant catalyst for pot businesses.

3 Reasons Why You Should Hold Off on Chevron Stock

Chevron stock offers several positives in this down market, but three major headwinds make CVX a difficult proposition.

The Weakness of Micron Stock Has Created a Good Buying Opportunity

MU stock absorbed a devastating hit after a disappointing Q1 earnings report, but the longer-term outlook of Micron stock is upbeat.

7 Stocks to Buy and Hold Through Any Market Selloff

While panicking is a natural reaction, these are seven stocks to buy for investors looking for tremendous value and upside potential.

The 5 Best Investment Strategies for a Volatile Market

Panicking during severe market selloffs is a natural reaction, but here are the best investments to make during market volatility.

Disney Stock Is a Sound Investment in an Unsound Market

Disney stock is loaded with an embarrassing array of upside catalysts, but even this stalwart can’t avoid broader market weaknesses.

Activision Stock Looks Poised to Rebound From Plunge

Fortnite mania has hammered ATVI stock, but the decline of ATVI has made it a much more sensible investment.

7 Major Pharmaceutical Stocks to Quarantine Now

Despite their indispensable demand, pharmaceutical stocks face tough roadblocks as competition for breakthrough drugs intensifies.